Qualms about gastrointestinal safety and lack of data in older age groups did not deter the FDA’s Allergenic Products Advisory Committee from giving its nod to recommend approval of Ragwitek, the sublingual ragweed allergy therapy for adults from Merck & Co. Inc. and Alk-Abello A/S.